Product Information

IBUPROFEN 800 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.0585 per EA under NDC 65162046610. Its NADAC has been published 399 times since Dec 12, 2018.

FDA first approved this application on Jun 18, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IBUPROFEN 800 MG TABLET

Ibuprofen
$0.0585per EA

Strength

800 mg/1

NDC

65162046610

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA078558

FDA Approved

6/18/2007

TE Code

AB

On Market Since

11/23/2009

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for IBUPROFEN 800 MG TABLET has been published 399 times since Dec 12, 2018, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0585 per EA
All-time high$0.0933 (Mar 11, 2020)
All-time low$0.0511 (Nov 20, 2024)
52-week high$0.0601
52-week low$0.0549
Median price$0.0696
Average price$0.0702
Largest weekly change-20.3% (Apr 17, 2024)
Weeks tracked399
Tracking sinceDec 12, 2018

Price History

1W

+5.1%

1M

+4.4%

3M

+3.1%

6M

+6.5%

1Y

-2.7%

3Y

-9.8%

5Y

-23.5%

All

+0.7%

Generic Alternatives

The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of IBUPROFEN 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 800 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $0.0585 per EA (NDC 65162046610), effective Aug 19, 2026.

How has the price of IBUPROFEN 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for IBUPROFEN 800 MG TABLET has held within roughly two percent of its current level. It has been tracked across 399 weekly CMS publications since Dec 12, 2018.

What are the highest and lowest recorded NADAC prices for IBUPROFEN 800 MG TABLET?

Since Dec 12, 2018, the NADAC for IBUPROFEN 800 MG TABLET has ranged from a low of $0.0511 (Nov 20, 2024) to a high of $0.0933 (Mar 11, 2020), with a median of $0.0696 per EA.

Are there cheaper alternatives to IBUPROFEN 800 MG TABLET?

Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 800 MG TABLET, is $0.0567 per EA — about 3% below IBUPROFEN 800 MG TABLET.

Who manufactures IBUPROFEN 800 MG TABLET?

IBUPROFEN 800 MG TABLET (NDC 65162046610) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.